Overview

Efficacy Study Of Tofacitinib In Pediatric JIA Population

Status:
Completed
Trial end date:
2019-05-16
Target enrollment:
Participant gender:
Summary
Evaluate efficacy, safety and tolerability of tofacitinib in pediatric JIA patients.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Pharmaceutical Solutions
Tofacitinib